All lobbying filings

TERUMO BCT, INC.

Lobbying for TERUMO BCT, INC. · Medical technology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Colorado · House · Senate · $20,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

S 735
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
HR 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Lobbying activity 2

Trade (domestic/foreign)

Global trade and tariffs

Health Issues

S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Blood and cell collection, storage, and processing Blood donation supply and quality

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.